Prognosis of pancreaticoduodenectomy in octogenarians for pancreatic ductal adenocarcinoma with propensity score matched analysis

被引:1
|
作者
Jeong, Hyejeong [1 ]
Lim, Soo Yeun [1 ]
Jeon, Hyun Jeong [1 ]
Yoon, So Jeong [1 ]
Kim, Hongbeom [1 ]
Han, In Woong [1 ]
Heo, Jin Seok [1 ]
Shin, Sang Hyun [1 ,2 ]
机构
[1] Sungkyunkwan Univ, Div Hepatobiliary Pancreat Surg, Dept Surg, Samsung Med Ctr,Sch Med, Seoul, South Korea
[2] Sungkyunkwan Univ, Samsung Med Ctr, Dept Surg, Div Hepatobiliary Pancreat Surg,Sch Med, 81 Irwon Ro, Seoul, South Korea
关键词
octogenarian; pancreatic ductal adenocarcinoma; pancreaticoduodenectomy; propensity score matching; ELDERLY-PATIENTS; SURGICAL-TREATMENT; COLORECTAL-CANCER; TERM OUTCOMES; SURVIVAL; CHEMOTHERAPY; RESECTION; SURGERY; THERAPY; COHORT;
D O I
10.1111/ans.18679
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: This retrospective study investigates factors affecting surgical and oncological outcome after performing pancreaticoduodenectomy in octogenarian patients diagnosed with pancreatic ductal adenocarcinoma.Methods: From January 2009 to December 2018, patients who underwent pancreaticoduodenectomy for pancreatic ductal adenocarcinoma were included. Data were analysed by comparing clinicopathological characteristics, complications, survival, recurrence, adjuvant treatment between octogenarians and the younger group. Propensity score matched analysis was performed due to the small size of the octogenarian group.Results: A total of 666 patients were included in this study and 24 (3.6%) were included in the octogenarian group. Short term complication rates (P = 0.119) and hospital stay (P = 0.839) did not differ between two groups. Overall survival between the two groups showed significant difference (<80 median 25 months versus =80 median 13 months, P = 0.045). However, after propensity score matched analysis, the two groups did not differ in overall survival (<80 median 18 months versus & GE;80 median survival 16 months, P = 0.565) or disease-free survival (P = 0.471). Among the octogenarians, six patients survived longer than 24 months even without satisfying all favourable prognostic factors.Conclusion: Considering the general condition of octogenarians diagnosed with pancreatic ductal adenocarcinoma, select patients should be treated more aggressively for the best chance of receiving curative treatment.
引用
收藏
页码:2655 / 2663
页数:9
相关论文
共 50 条
  • [41] Predictors and outcomes of converted minimally invasive pancreaticoduodenectomy: a propensity score matched analysis
    Caitlin A. Hester
    Ibrahim Nassour
    Alana Christie
    Mathew M. Augustine
    John C. Mansour
    Patricio M. Polanco
    Matthew R. Porembka
    Thomas H. Shoultz
    Sam C. Wang
    Adam C. Yopp
    Herbert J. Zeh
    Rebecca M. Minter
    Surgical Endoscopy, 2020, 34 : 544 - 550
  • [42] Neoadjuvant therapy versus upfront surgery for resected pancreatic adenocarcinoma: A nationwide propensity score matched analysis
    de Geus, Susanna W. L.
    Eskander, Mariam F.
    Bliss, Lindsay A.
    Kasumova, Gyulnara G.
    Ng, Sing Chau
    Gallery, Mark P.
    Tseng, Jennifer F.
    SURGERY, 2017, 161 (03) : 592 - 601
  • [43] Potential Impact of Phellinus linteus on Adherence to Adjuvant Treatment After Curative Resection of Pancreatic Ductal Adenocarcinoma: Outcomes of a Propensity Score-Matched Analysis
    Lee, Sung Hwan
    Hwang, Ho Kyoung
    Kang, Chang Moo
    Lee, Woo Jung
    INTEGRATIVE CANCER THERAPIES, 2018, 18
  • [44] Clinical presentation and prognosis of adenosquamous carcinoma of the pancreas-Matched-pair analysis with pancreatic ductal adenocarcinoma
    Kaiser, Joerg
    Hinz, Ulf
    Mayer, Philipp
    Hank, Thomas
    Niesen, Willem
    Hackert, Thilo
    Gaida, Matthias M.
    Buechler, Markus W.
    Strobel, Oliver
    EJSO, 2021, 47 (07): : 1734 - 1741
  • [45] A quantitative score of immune cell infiltration predicts the prognosis in pancreatic ductal adenocarcinoma
    Zhi-gang Chen
    Wang, Yun
    Fong, William Pat
    Ming-tao Hu
    Jie-ying Liang
    Wang, Lingyun
    Yu-hong Li
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 98
  • [46] Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
    Flis, Vojko
    Potrc, Stojan
    Kobilica, Nina
    Ivanecz, Arpad
    RADIOLOGY AND ONCOLOGY, 2016, 50 (03) : 321 - 328
  • [47] Mesenteric approach during pancreaticoduodenectomy for pancreatic ductal adenocarcinoma
    Hirono, Seiko
    Kawai, Manabu
    Okada, Ken-ichi
    Miyazawa, Motoki
    Shimizu, Atsushi
    Kitahata, Yuji
    Ueno, Masaki
    Shimokawa, Toshio
    Nakao, Akimasa
    Yamaue, Hiroki
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2017, 1 (03): : 208 - 218
  • [48] Negative Impact of Preoperative Endoscopic Biliary Drainage on Prognosis of Pancreatic Ductal Adenocarcinoma After Pancreaticoduodenectomy
    Furukawa, Kenei
    Shiba, Hiroaki
    Shirai, Yoshihiro
    Horiuchi, Takashi
    Iwase, Ryota
    Haruki, Koichiro
    Fujiwara, Yuki
    Misawa, Takeyuki
    Yanaga, Katsuhiko
    ANTICANCER RESEARCH, 2015, 35 (09) : 5079 - 5083
  • [49] Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study
    Sanne Lof
    Maarten Korrel
    Jony van Hilst
    Adnan Alseidi
    Gianpaolo Balzano
    Ugo Boggi
    Giovanni Butturini
    Riccardo Casadei
    Safi Dokmak
    Bjørn Edwin
    Massimo Falconi
    Tobias Keck
    Giuseppe Malleo
    Matteo de Pastena
    Ales Tomazic
    Hanneke Wilmink
    Alessandro Zerbi
    Marc G. Besselink
    Mohammed Abu Hilal
    Annals of Surgical Oncology, 2020, 27 : 1986 - 1996
  • [50] Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study
    Lof, Sanne
    Korrel, Maarten
    van Hilst, Jony
    Alseidi, Adnan
    Balzano, Gianpaolo
    Boggi, Ugo
    Butturini, Giovanni
    Casadei, Riccardo
    Dokmak, Safi
    Edwin, Bjorn
    Falconi, Massimo
    Keck, Tobias
    Malleo, Giuseppe
    de Pastena, Matteo
    Tomazic, Ales
    Wilmink, Hanneke
    Zerbi, Alessandro
    Besselink, Marc G.
    Abu Hilal, Mohammed
    Bonds, Morgan
    Capretti, Giovanni
    Fiorentini, Guido
    Giardino, Alessandro
    Lombardo, Carlo
    Ricci, Claudio
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (06) : 1986 - 1996